Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Olson

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusJason P Gardner, Robert J Durso, Robert R Arrigale, et al.
Plos One|June 16, 2022
Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primatesKishor Devalaraja-Narashimha, Cong Huang, Marc Cao, et al.
Nature Communications|November 12, 2024
Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexesYi Zhou, Panayiotis E Stevis, Jing Cao, et al.
Proteomics|May 24, 2016
Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscleRobert R Salzler, Darshit Shah, Anthony Doré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigenDangshe Ma, Christine E Hopf, Andrew D Malewicz, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Journal of Virology|January 29, 2003
Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cellsThomas J Ketas, Ines Frank, Per Johan Klasse, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Nature Structural & Molecular Biology|September 23, 2024
Structural insights into CXCR4 modulation and oligomerizationKei Saotome, Luke L McGoldrick, Jo-Hao Ho, et al.
Plos One|July 11, 2013
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersIlja Bontjer, Mark Melchers, Tommy Tong, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2003
L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virusJason P Gardner, Robert J Durso, Robert R Arrigale, et al.
Plos One|June 16, 2022
Pharmacokinetics and pharmacodynamics of pozelimab alone or in combination with cemdisiran in non-human primatesKishor Devalaraja-Narashimha, Cong Huang, Marc Cao, et al.
Nature Communications|November 12, 2024
Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexesYi Zhou, Panayiotis E Stevis, Jing Cao, et al.
Proteomics|May 24, 2016
Myostatin deficiency but not anti-myostatin blockade induces marked proteomic changes in mouse skeletal muscleRobert R Salzler, Darshit Shah, Anthony Doré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2006
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigenDangshe Ma, Christine E Hopf, Andrew D Malewicz, et al.
Journal of Virology|July 5, 2005
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Simon Beddows, Norbert Schülke, Marc Kirschner, et al.
Journal of Virology|January 29, 2003
Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cellsThomas J Ketas, Ines Frank, Per Johan Klasse, et al.
Virology|May 5, 2009
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivoKaustuv Banerjee, Sofija Andjelic, Per Johan Klasse, et al.
Nature Structural & Molecular Biology|September 23, 2024
Structural insights into CXCR4 modulation and oligomerizationKei Saotome, Luke L McGoldrick, Jo-Hao Ho, et al.
Plos One|July 11, 2013
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersIlja Bontjer, Mark Melchers, Tommy Tong, et al.
Pageof 8